Your browser doesn't support javascript.
loading
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
Timmerman, John; Herbaux, Charles; Ribrag, Vincent; Zelenetz, Andrew D; Houot, Roch; Neelapu, Sattva S; Logan, Theodore; Lossos, Izidore S; Urba, Walter; Salles, Gilles; Ramchandren, Radhakrishnan; Jacobson, Caron; Godwin, John; Carpio, Cecilia; Lathers, Deanne; Liu, Yali; Neely, Jaclyn; Suryawanshi, Satyendra; Koguchi, Yoshinobu; Levy, Ronald.
Afiliación
  • Timmerman J; UCLA Medical Center, Los Angeles, California.
  • Herbaux C; Centre Hospitalier Régional Universitaire de Lille, Lille, France.
  • Ribrag V; Institut Gustave Roussy, Villejuif, France.
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Houot R; CHU Rennes, Service Hématologie Clinique, Rennes, France.
  • Neelapu SS; INSERM, Unité d'Investigation Clinique, Rennes, France.
  • Logan T; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lossos IS; Simon Cancer Center, Indiana University, Indianapolis, Indiana.
  • Urba W; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida.
  • Salles G; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon.
  • Ramchandren R; Hospices Civils de Lyon, Université de Lyon, Lyon, France.
  • Jacobson C; Karmanos Cancer Institute, Detroit, Michigan.
  • Godwin J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Carpio C; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon.
  • Lathers D; Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Liu Y; Bristol-Myers Squibb, Princeton, New Jersey.
  • Neely J; Bristol-Myers Squibb, Princeton, New Jersey.
  • Suryawanshi S; Bristol-Myers Squibb, Princeton, New Jersey.
  • Koguchi Y; Bristol-Myers Squibb, Princeton, New Jersey.
  • Levy R; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon.
Am J Hematol ; 95(5): 510-520, 2020 05.
Article en En | MEDLINE | ID: mdl-32052473

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Rituximab / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Rituximab / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article